It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 04640cam 22008294a 4500
001 ocm57730829
003 OCoLC
005 20200527040559.0
008 050217s2005 flua b 001 0 eng
010 $a 2005045702
040 $aDLC$beng$cDLC$dPMC$dCUX$dBAKER$dNLM$dNLGGC$dBTCTA$dLVB$dYDXCP$dSTF$dDEBBG$dOCLCQ$dOCL$dIG#$dA7U$dOCLCQ$dTULIB$dBDX$dOCLCF$dCRCPR$dOCLCQ$dOCLCO$dSSJ$dOCLCQ$dI8M$dOCLCO$dOCLCA$dTHHCU$dVGM$dTHHCU$dOCLCQ$dCSJ$dOCLCQ$dTYC$dRCE$dLEATE$dMUX$dOCLCA$dCASUM$dTPN$dBUF$dGILDS$dAPUMS$dOCLCQ$dWYU$dOCLCQ
016 7 $a101249522$2DNLM
019 $a733156003
020 $a0824725794
020 $a9780824725792
024 3 $a9780824725792
035 $a(OCoLC)57730829$z(OCoLC)733156003
042 $apcc
050 00 $aR857.N34$bB557 2005
060 00 $a2005 G-872
060 10 $aQT 36$bB61552 2005
082 00 $a610/.28$222
084 $a44.31$2bcl
084 $aXC 4000$2rvk
084 $aFEI 390f$2stub
084 $aTEC 030f$2stub
245 00 $aBiomedical nanotechnology /$cedited by Neelina H. Malsch.
260 $aBoca Raton :$bTaylor & Francis,$c2005.
300 $a209 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aConverging technologies : nanotechnology and biomedicine / Mihail C. Roco -- Trends in biomedical nanotechnology programs worldwide / Mark Morrison and Ineke Malsch -- Nanotechnology and trends in drug delivery systems with self-assembled carriers / Kenji Yamamoto -- Implants and prostheses / Jeroen J.J.P. van den Beucken, X. Frank Walboomers, and John A. Jansen -- Diagnostics and high throughput screening / Aránzazu del Campo and Ian J. Bruce -- Nano-enabled components and systems for biodefense / Calvin Shipbaugh [and others] -- Social and economic contexts : making choices in the development of biomedical nanotechnology / Ineke Malsch -- Potential risks and remedies / Emmanuelle Schuler.
530 $aAlso available on the Internet.
520 1 $a"Contributed by experts in this expansive and interdisciplinary field, Biomedical Nanotechnology examines developments in three sub-fields: nanodrugs and drug delivery; prostheses and implants; and diagnostics and screening technologies. The authors compare new capabilities introduced by nanotechnology to traditional methods of release, target, and controlled drug delivery in the body. They also consider the challenge of understanding and controlling the biological processes involved upon implantation and discuss nanoscale sensors for biological chemical detection and biodefense. The book concludes with individual chapters devoted to the social and economic context of nanotechnologies and to their potential risks and possible solutions."--Jacket.
650 0 $aNanotechnology.
650 0 $aMedical technology.
650 0 $aBiomedical engineering.
650 12 $aNanotechnology.
650 22 $aBiomedical Engineering.
650 6 $aNanotechnologie.
650 6 $aTechnologie médicale.
650 6 $aGénie biomédical.
650 7 $aBiomedical engineering.$2fast$0(OCoLC)fst00832568
650 7 $aMedical technology.$2fast$0(OCoLC)fst01014742
650 7 $aNanotechnology.$2fast$0(OCoLC)fst01032639
650 7 $aBiomedizinische Technik$2gnd
650 7 $aNanotechnologie$2gnd
650 4 $aNanotecnología.
650 4 $aTecnología médica.
650 4 $aIngeniería biomédica.
700 1 $aMalsch, Neelina H.
856 41 $3CRCnetBASE$uhttp://www.crcnetbase.com/isbn/9781420028621
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=014565355&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
856 41 $uhttps://www.taylorfrancis.com/books/e/9781420028621$zAccess restricted to Stanford community
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/enhancements/fy0648/2005045702-d.html
938 $aBaker & Taylor$bBKTY$c139.95$d.00$i0824725794$n0006272393$sactive
938 $aBrodart$bBROD$n04398556$c$139.95
938 $aBaker and Taylor$bBTCP$n2005045702
938 $aCRC Press$bCRCP$nCRC00DK2453000
938 $aIngram$bINGR$n9780824725792
938 $aYBP Library Services$bYANK$n2184408
029 1 $aAU@$b000026748917
029 1 $aDEBBG$bBV021243830
029 1 $aHEBIS$b135516692
029 1 $aNLGGC$b27364551X
029 1 $aNLM$b101249522
029 1 $aNZ1$b9179457
029 1 $aYDXCP$b2184408
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 237 OTHER HOLDINGS